Elucidating the Role of PIK3CA in Early-Stage Bladder Tumorigenesis
The American Journal of Pathology · 2023
DOI: 10.1016/j.ajpath.2023.10.001 ↗Kurz gefasst
Kommentar in der Zeitschrift The American Journal of Pathology, 2023. Verfasst von Bishoy M Faltas. Beteiligte Einrichtung: Division of Hematology and Medical Oncology, Department of Medicine, Weill Cornell Medicine/New York-Presbyterian, New York, New York. Electronic add…. Hauptthemen laut MEDLINE: Urinary Bladder, Cell Transformation, Neoplastic. Die Arbeit nennt 2 Literaturangaben.
Abstract (Originalsprache)
More than 70% of bladder cancers are nonmuscle invasive bladder cancers. 1 Despite the high prevalence of nonmuscle invasive bladder cancers, there are signi fi cant gaps in our understanding of the early stages of bladder tumorigenesis. A landmark study by Shuman et al 2 addresses this critical knowledge gap, focusing on the role of phos-phatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit a ( PIK3CA ) e activating mutations, identi fi ed across different stages of bladder cancer as one of the most prevalent oncogenic mutations
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Division of Hematology and Medical Oncology, Department of Medicine, Weill Cornell Medicine/New York-Presbyterian, New York, New York. Electronic address: bmf9003@med.cornell.edu.
Zitieren
APA
Faltas, B. M. (2023). Elucidating the Role of PIK3CA in Early-Stage Bladder Tumorigenesis. The American Journal of Pathology. https://doi.org/10.1016/j.ajpath.2023.10.001
Vancouver
Faltas BM. Elucidating the Role of PIK3CA in Early-Stage Bladder Tumorigenesis. The American Journal of Pathology. 2023. doi:10.1016/j.ajpath.2023.10.001
BibTeX
@article{Faltas2023,
author = {Faltas, Bishoy M},
title = {Elucidating the Role of PIK3CA in Early-Stage Bladder Tumorigenesis},
journal = {The American Journal of Pathology},
year = {2023},
doi = {10.1016/j.ajpath.2023.10.001}
}
EUVIMED